Good morning fellow rocketlab bagholders, Wendy's milkshakers, and YouTube premium subscribers. Here to tell you about RNXT which reobtained NASDAQ listing status recently.
I'm an RN (regarded nurse) in the southeast and we recently started using Renovo to treat patients with pancreatic cancer, one of the most deadly cancers with the least amount of treatment options. ✅ Renovo allows chemotherapy treatments to become more localized within the vasculature of your body, making harder to reach targets more accessible and reducing the amount of systemic chemotherapy ✅ Renovo is also seeing potential in other forms of cancer but is not being fully utilized for it yet ✅ Our patient list for this treatment is booming and we're not even a hospital (even though we're one of the largest in the nation) listed on their website yet meaning their growth is outpacing their marketing team's brains ✅ and lastly our radiologists our shocked at the results of the treatments so far ✅
All this to say, it's dirt cheap at $2 and last quarters results show massive interest in this company's product. On September 14th they are presenting at the H.C. Wainwright 28th Annual Global Investment Conference, likely to garner more attention and investment interest.
I'm not a math's whiz, don't know much about the company's execs, but this is a casino and I may have gotten lucky finally.